Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis C

D S Sherlock1

  • 1Department of Medicine, Royal Free Hospital School of Medicine, University of London, United Kingdom.

Disease-A-Month : DM
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) infection is diagnosed with antibody tests, but transmission routes for many cases remain unclear. Treatment with interferon-alpha shows limited efficacy, with a 25% overall response rate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical expression of HDV infection: presentation of illustrative cases.

Progress in clinical and biological research·1993
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) was identified in 1989, leading to antibody tests (anti-HCV).
  • HCV is linked to post-transfusion hepatitis, hepatocellular carcinoma, and chronic liver disease.
  • Diagnosis historically relied on excluding other causes of non-A, non-B hepatitis.

Purpose of the Study:

  • To review the current understanding of Hepatitis C virus (HCV) infection.
  • To discuss diagnostic methods, transmission, and clinical manifestations of HCV.
  • To evaluate treatment options and outcomes for chronic HCV infection.

Main Methods:

  • Review of scientific literature on Hepatitis C virus (HCV).
  • Analysis of diagnostic advancements, including antibody and RNA detection.

Related Experiment Videos

  • Examination of epidemiological data and clinical case studies.

    • Main Results:

    • Anti-HCV tests are widely available, with 0.5-1% prevalence in blood donors.
    • Parenteral exposure (transfusion, drug abuse) is a primary transmission route; other routes remain uncertain.
    • Acute HCV is often mild, chronic disease indolent but can lead to cirrhosis and cancer; interferon-alpha yields a 25% sustained response rate.

    Conclusions:

    • HCV diagnosis and understanding have advanced significantly since 1989.
    • Clarifying HCV transmission and improving treatment efficacy are critical research areas.
    • Distinguishing HCV from autoimmune hepatitis and managing complications like cancer are key clinical challenges.